BNP Paribas Fortis
Bank
Active
20
94M
16
1.25
0.20
2
- Stages of investment
- Areas of investment
Summary
BNP Paribas Fortis is the famous Corporate Investor, which was founded in 2008. The company was established in Europe in Belgium. The main office of represented Corporate Investor is situated in the Brussels.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the BNP Paribas Fortis, startups are often financed by S.R.I.W., Vesalius Biocapital Partners. The meaningful sponsors for the fund in investment in the same round are Vesalius Biocapital Partners, University of Leuven, Ulster Bank Ireland.
The top amount of exits for fund were in 2017. The real fund results show that this Corporate Investor is 13 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. Deals in the range of 50 - 100 millions dollars are the general things for fund. This BNP Paribas Fortis works on 4 percentage points more the average amount of lead investments comparing to the other organizations.
The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight reMYND, Ogeda. Among the most popular fund investment industries, there are Health Care, Biotechnology. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - Belgium.
We also calculated 13 valuable employees in our database.
Investor highlights
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 20
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 1.25
- Follow on index
- 0.20
- Investments by industry
- Biotechnology (5)
- Logistics (4)
- Software (4)
- Health Care (3)
- SaaS (3) Show 40 more
- Investments by region
-
- Germany (1)
- Belgium (15)
- Ireland (1)
- United Kingdom (2)
- United States (1)
- Peak activity year
- 2022
- Number of Unicorns
- 2
- Number of Decacorns
- 2
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Avg. valuation at time of investment
- 105M
- Group Appearance index
- 0.95
- Avg. company exit year
- 12
- Avg. multiplicator
- 0.32
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Ogeda | 02 Oct 2015 | Biotechnology, Health Care, Health Diagnostics, Pharmaceutical | Early Stage Venture | 18M | Brussels-Capital, City of Brussels, Belgium |
| Vaultspeed | 16 Nov 2023 | Software, SaaS | Early Stage Venture | 17M | Flemish Brabant, Leuven, Belgium |
Similar funds
By same location
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.